NCT06416085 2026-03-05
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
University Health Network, Toronto
Phase 2 Active not recruiting
Clinical Trials
19 trialsNCT06200155 2026-03-03
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06801041 2026-03-03
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06827054 2026-02-18
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
NCT04950608 2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2 Completed
NCT07216404 2026-02-10
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT07336238 2026-02-09
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
Phase 2 Not yet recruiting
NCT05220046 2025-12-17
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
University of Nebraska
Phase 1 Active not recruiting
NCT06001749 2025-12-16
Psilocybin in Cancer Pain Study
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT05847686 2025-11-05
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
University of Washington
Phase 1/2 Completed
NCT06644170 2025-10-14
A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer
University of Washington
Phase 1 Completed
NCT05506982 2025-07-23
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
Emory University
Phase 1 Completed
NCT07048743 2025-07-11
PEARL-C1
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT06430541 2025-07-04
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
University of Colorado, Denver
Phase 1 Recruiting
NCT00302744 2025-03-13
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 1/2 Completed
NCT04522804 2024-03-20
HOPE
University of Utah
Phase EARLY_PHASE1 Completed
NCT04593563 2021-10-15
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Maryland Oncology Hematology, PA
Phase 2 Unknown
NCT00957359 2020-10-20
Psilocybin Cancer Anxiety Study
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT00465595 2018-07-19
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Phase 2 Completed